InvestorsHub Logo
Followers 32
Posts 2552
Boards Moderated 0
Alias Born 07/16/2006

Re: gfp927z post# 32379

Sunday, 02/21/2010 7:58:20 PM

Sunday, February 21, 2010 7:58:20 PM

Post# of 51150
OT:ALXA
I personally don't see a large home-use market. My projections have been based on psych beds, CMHCs, ERs.

I am not attributing much if any value to the migraine program. Alexza needs to find new payloads/indications, and there are lots of compounds which are not suitable for this inhalant system.

Tom King did a good job with Anesta, and now with Alexza. Biovail will be a solid, aggressive partner for this product.

NeuroInvestment
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News